Stirling Edwards

1.5k total citations
34 papers, 1.2k citations indexed

About

Stirling Edwards is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Stirling Edwards has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Stirling Edwards's work include Viral Infectious Diseases and Gene Expression in Insects (6 papers), Influenza Virus Research Studies (5 papers) and Virus-based gene therapy research (5 papers). Stirling Edwards is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (6 papers), Influenza Virus Research Studies (5 papers) and Virus-based gene therapy research (5 papers). Stirling Edwards collaborates with scholars based in Australia, United Kingdom and United States. Stirling Edwards's co-authors include David Pye, Robin F. Anders, Billy G. Hudson, Mai B. Margetts, Pauline E. Crewther, Philip Sutton, J. Wieslander, Per Bygren, Ralph J. Butkowski and Dick Heinegård and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Stirling Edwards

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stirling Edwards Australia 20 390 342 301 287 152 34 1.2k
Chantal Tougne Switzerland 21 232 0.6× 1.0k 3.0× 427 1.4× 305 1.1× 35 0.2× 31 1.7k
Ellis van Liempt Netherlands 14 121 0.3× 1.0k 3.0× 292 1.0× 555 1.9× 57 0.4× 20 1.7k
Vanitha S. Raman United States 18 661 1.7× 1.1k 3.1× 561 1.9× 355 1.2× 37 0.2× 22 2.0k
Gerald Aichinger Austria 19 109 0.3× 647 1.9× 397 1.3× 336 1.2× 34 0.2× 31 1.2k
Theresa A. Banks United States 19 95 0.2× 1.2k 3.5× 581 1.9× 292 1.0× 58 0.4× 25 1.8k
Nadia L. Bernasconi United States 9 239 0.6× 1.5k 4.4× 721 2.4× 252 0.9× 32 0.2× 9 2.3k
Gustaf Ahlén Sweden 18 59 0.2× 280 0.8× 342 1.1× 237 0.8× 128 0.8× 38 1.0k
Minh-Duc Nguyen United States 9 67 0.2× 1.3k 3.7× 227 0.8× 390 1.4× 220 1.4× 9 1.7k
I. McConnell United Kingdom 27 129 0.3× 1.0k 3.0× 572 1.9× 258 0.9× 75 0.5× 68 1.9k
Leonia Bozzacco United States 16 131 0.3× 879 2.6× 195 0.6× 445 1.6× 36 0.2× 21 1.2k

Countries citing papers authored by Stirling Edwards

Since Specialization
Citations

This map shows the geographic impact of Stirling Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stirling Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stirling Edwards more than expected).

Fields of papers citing papers by Stirling Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stirling Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stirling Edwards. The network helps show where Stirling Edwards may publish in the future.

Co-authorship network of co-authors of Stirling Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Stirling Edwards. A scholar is included among the top collaborators of Stirling Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stirling Edwards. Stirling Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boo, Irene, Jun Gu, Kathleen McCaffrey, et al.. (2016). The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs. Hepatology. 65(4). 1117–1131. 56 indexed citations
2.
Snibson, Kenneth J., et al.. (2015). ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza. Human Vaccines & Immunotherapeutics. 11(2). 377–385. 8 indexed citations
3.
Stent, Andrew, Alison L. Every, Garrett Z. Ng, et al.. (2012). Helicobacter pylori thiolperoxidase as a protective antigen in single- and multi-component vaccines. Vaccine. 30(50). 7214–7220. 25 indexed citations
4.
Wee, Janet L., Kenneth J. Snibson, Stirling Edwards, et al.. (2010). Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX™ adjuvanted recombinant antigens. Vaccine. 28(14). 2593–2597. 24 indexed citations
5.
Every, Alison L., Andrew Stent, Garrett Z. Ng, et al.. (2010). Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen. Vaccine. 29(7). 1514–1518. 19 indexed citations
6.
Harbour, Stacey N., Alison L. Every, Stirling Edwards, & Philip Sutton. (2008). Systemic Immunization with Unadjuvanted Whole Helicobacter pylori Protects Mice Against Heterologous Challenge. Helicobacter. 13(6). 494–499. 4 indexed citations
7.
Wee, Janet L., Jean‐Pierre Y. Scheerlinck, Kenneth J. Snibson, et al.. (2008). Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing. Mucosal Immunology. 1(6). 489–496. 51 indexed citations
8.
Scheerlinck, Jean‐Pierre Y., et al.. (2006). Local immune responses following nasal delivery of an adjuvanted influenza vaccine. Vaccine. 24(18). 3929–3936. 18 indexed citations
9.
Webb, Elizabeth, J. Thomas Cox, & Stirling Edwards. (2005). Cervical Cancer-causing Human Papillomaviruses have an Alternative Initiation Site for the L1 Protein. Virus Genes. 30(1). 31–35. 9 indexed citations
10.
Stewart, Trina J., Debbie Drane, John C. Cox, et al.. (2004). ISCOMATRIX™ adjuvant: an adjuvant suitable for use in anticancer vaccines. Vaccine. 22(27-28). 3738–3743. 31 indexed citations
11.
Anders, Robin F., et al.. (1998). Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine. 16(2-3). 240–247. 179 indexed citations
12.
Webb, Elizabeth, et al.. (1996). Enhanced secretory ability for the human factor VIII light chain produced in baculovirus-infected insect cells. Cytotechnology. 21(2). 165–170. 1 indexed citations
13.
Jagadish, Mittur N., Stirling Edwards, Kirsten Vandenberg, et al.. (1996). Chimeric Potyvirus-Like Particles as Vaccine Carriers. Intervirology. 39(1-2). 85–92. 36 indexed citations
14.
Edwards, Stirling, et al.. (1994). High level production of potyvirus-like particles in insect cells infected with recombinant baculovirus. Archives of Virology. 136(3-4). 375–380. 10 indexed citations
15.
Collins, W E, David Pye, Kirsten Vandenberg, et al.. (1994). Protective Immunity Induced in Squirrel Monkeys with Recombinant Apical Membrane Antigen-1 of Plasmodium fragile. American Journal of Tropical Medicine and Hygiene. 51(6). 711–719. 145 indexed citations
16.
McGowan, Eileen, et al.. (1994). Expression and characterisation of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus. Archives of Virology. 137(3-4). 389–395. 7 indexed citations
17.
Webb, Elizabeth, et al.. (1993). Expression of Biologically Active Human Factor VIII Using a Baculovirus Vector. Biochemical and Biophysical Research Communications. 190(2). 536–543. 5 indexed citations
19.
Kemball‐Cook, Geoffrey, et al.. (1988). Factor VIII Procoagulant Protein Interacts with Phospholipid Vesicles Via its 80 kDa Light Chain. Thrombosis and Haemostasis. 60(3). 442–446. 19 indexed citations
20.
Wieslander, J., Ralph J. Butkowski, Stirling Edwards, et al.. (1984). Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen.. Proceedings of the National Academy of Sciences. 81(12). 3838–3842. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026